{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:40:27Z","timestamp":1773276027995,"version":"3.50.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2002,3,1]]},"DOI":"10.1038\/sj.jhh.1001354","type":"journal-article","created":{"date-parts":[[2002,9,5]],"date-time":"2002-09-05T18:39:12Z","timestamp":1031251152000},"page":"S104-S113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Diuretics in the treatment of patients who present congestive heart failure and hypertension"],"prefix":"10.1038","volume":"16","author":[{"given":"A J","family":"Reyes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,4,24]]},"reference":[{"key":"BF1001354_CR1","first-page":"75","volume":"10\/3","author":"AJ Reyes","year":"1995","unstructured":"Reyes AJ . Pathophysiological basis of the use of diuretics in congestive heart failure Prog Pharmacol Clin Pharmacol 1995 10\/3: 75\u201389","journal-title":"Prog Pharmacol Clin Pharmacol"},{"key":"BF1001354_CR2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/j.1552-4604.1979.tb02470.x","volume":"19","author":"EL Coodley","year":"1979","unstructured":"Coodley EL, Nandi PS, Chiotellis P . Evaluation of a new diuretic, diapamide, in congestive heart failure J Clin Pharmacol 1979 19: 127\u2013136","journal-title":"J Clin Pharmacol"},{"key":"BF1001354_CR3","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/j.1552-4604.1981.tb05683.x","volume":"21","author":"DW Dixon","year":"1981","unstructured":"Dixon DW, Barwold-Gohlke C, Gunnar RM . Comparative efficacy and safety of bumetamide and furosemide in long-term treatment of edema due to congestive heart failure J Clin Pharmacol 1981 21: 680\u2013687","journal-title":"J Clin Pharmacol"},{"key":"BF1001354_CR4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF00541540","volume":"30","author":"AJF K\u00fcpper","year":"1986","unstructured":"K\u00fcpper AJF et al. Cross-over comparison of the fixed combination of hydrochlorothiazide and triamterene and the free combination of furosemide and triamterene in the maintenance treatment of congestive heart failure Eur J Clin Pharmacol 1986 30: 341\u2013343","journal-title":"Eur J Clin Pharmacol"},{"key":"BF1001354_CR5","first-page":"127","volume":"8\/1","author":"l Achhammer","year":"1990","unstructured":"Achhammer l . Long term efficacy and tolerance of torasemide in congestive heart failure Prog Pharmacol Clin Pharmacol 1990 8\/1: 127\u2013136","journal-title":"Prog Pharmacol Clin Pharmacol"},{"key":"BF1001354_CR6","first-page":"729","volume":"27","author":"W Rutishauser","year":"1960","unstructured":"Rutishauser W, Rhomberg F, Sack P . \u00dcber die Ver\u00e4nderungen der Kreislaufzeiten bei der Behandlung der h\u00e4modynamischen Herzinsuffizienz mit Diuretica und Herzglycosiden Helv Med Acta 1960 27: 729\u2013734","journal-title":"Helv Med Acta"},{"key":"BF1001354_CR7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1536\/ihj.25.571","volume":"25","author":"H Nishijima","year":"1984","unstructured":"Nishijima H et al. Acute and chronic hemodynamic effects of the basic therapeutic regimen for congestive heart failure. Diuretics, low salt diet and bed rest Jpn Heart J 1984 25: 571\u2013585","journal-title":"Jpn Heart J"},{"key":"BF1001354_CR8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/BF01857763","volume":"4","author":"W Haerer","year":"1990","unstructured":"Haerer W et al. Acute and chronic effects of diuretic monotherapy with piretanide in congestive heart failure\u2014a placebo-controlled trial Cardiovasc Drugs Ther 1990 4: 515\u2013522","journal-title":"Cardiovasc Drugs Ther"},{"key":"BF1001354_CR9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1071-9164(98)90054-9","volume":"4 (Suppl 1)","author":"E Sverzellati","year":"1998","unstructured":"Sverzellati E et al. Lung water is a critical determinant of functional capacity in congestive heart failure J Cardiac Fail 1998 4 (Suppl 1): 15 (abstract)","journal-title":"J Cardiac Fail"},{"key":"BF1001354_CR10","first-page":"91","volume-title":"Cardiovascular Pharmacotherapy. Proceedings of the 9th International Congress on Cardiovascular Pharmacotherapy","author":"AJ Reyes","year":"2000","unstructured":"Reyes AJ . The Stanley H. Taylor Memorial Lecture: diuretics in heart failure. Understanding the mechanism of the clinical improvement In: Reyes AJ,MaranhaAuml;o MFC (eds) Cardiovascular Pharmacotherapy. Proceedings of the 9th International Congress on Cardiovascular Pharmacotherapy Monduzzi: Bologna 2000 pp 91\u201395"},{"key":"BF1001354_CR11","doi-asserted-by":"crossref","first-page":"63C","DOI":"10.1016\/S0735-1097(97)83983-6","volume":"31","author":"G Crippa","year":"1998","unstructured":"Crippa G et al. Intrinsic possibilities of chest X-rays as a means to assess pulmonary congestion and water J Am Coll Cardiol 1998 31: 63C (abstract)","journal-title":"J Am Coll Cardiol"},{"key":"BF1001354_CR12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1071-9164(98)90167-1","volume":"4 (Suppl 1)","author":"E Sverzellati","year":"1998","unstructured":"Sverzellati E et al. Functional purport of the cardiothoracic ratio in congestive heart failure J Cardiac Fail 1998 4 (Suppl 1): 44 (abstract)","journal-title":"J Cardiac Fail"},{"key":"BF1001354_CR13","first-page":"855","volume":"33","author":"T Acosta-Barrios","year":"1983","unstructured":"Acosta-Barrios T, Reyes AJ, Leary WP, van der Byl K . Effects of xipamide in hypertensivepatients with cardiac insufficiency: a clinical appraisal Curr Ther Res 1983 33: 855\u2013859","journal-title":"Curr Ther Res"},{"key":"BF1001354_CR14","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1136\/bmj.292.6527.1030","volume":"292","author":"DP Lipkin","year":"1992","unstructured":"Lipkin DP, Poole-Wilson P . Symptoms limiting exercise in chronic heart failure BMJ 1992 292: 1030\u20131031","journal-title":"BMJ"},{"key":"BF1001354_CR15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/hrt.55.5.439","volume":"55","author":"DP Lipkin","year":"1986","unstructured":"Lipkin DP, Canepa-Anson R, Stephens MR, Poole-Wilson PA . Factors determining symptoms in heart failure: comparison of fast and slow exercise tests Br Heart J 1986 55: 439\u2013445","journal-title":"Br Heart J"},{"key":"BF1001354_CR16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1023\/A:1007739830030","volume":"11","author":"AJS Coats","year":"1997","unstructured":"Coats AJS . Origin of symptoms in heart failure Cardiovasc Drugs Ther 1997 11: 265\u2013272","journal-title":"Cardiovasc Drugs Ther"},{"key":"BF1001354_CR17","first-page":"332","volume-title":"Diuretics II: Chemistry, Pharmacology, and Clinical Applications","author":"AJ Reyes","year":"1987","unstructured":"Reyes AJ . Diuretics in heart failure. In: Puschett JB, Greenberg A (eds) Diuretics II: Chemistry, Pharmacology, and Clinical Applications Elsevier Science: New York 1987 332\u2013344"},{"key":"BF1001354_CR18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/978-1-4613-2067-8_82","volume-title":"Diuretics: Basic, Pharmacological, and Clinical Aspects","author":"AJ Reyes","year":"1987","unstructured":"Reyes AJ . Aspects of the mechanism of action of diuretics in heart failure. In: Andreucci VE, Dal Canton A (eds) Diuretics: Basic, Pharmacological, and Clinical Aspects Martinus Nijhoff: Boston 1987 344\u2013349"},{"key":"BF1001354_CR19","first-page":"167","volume":"6\/3","author":"AJ Reyes","year":"1988","unstructured":"Reyes AJ . Therapy with diuretics in congestive heart failure Prog Pharmacol 1988 6\/3: 167\u2013192","journal-title":"Prog Pharmacol"},{"key":"BF1001354_CR20","first-page":"441","volume":"9","author":"AJ Reyes","year":"1992","unstructured":"Reyes AJ . Actions of diuretics on the functional processes of congestive heart failure: from facts to heuristic hypotheses Prog Pharmacol Clin Pharmacol 1992 9: 441\u2013460","journal-title":"Prog Pharmacol Clin Pharmacol"},{"key":"BF1001354_CR21","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/BF00877717","volume":"7","author":"AJ Reyes","year":"1993","unstructured":"Reyes AJ . Loop diuretics versus others in the treatment of congestive heart failure after myocardial infarction Cardiovasc Drugs Ther 1993 7: 869\u2013876","journal-title":"Cardiovasc Drugs Ther"},{"key":"BF1001354_CR22","first-page":"61","volume":"77 (Suppl 5)","author":"R Zelis","year":"1988","unstructured":"Zelis R, Sinoway L, Musch T, Davis D . The peripheral distribution of cardiac output in heart failure Z Kardiol 1988 77 (Suppl 5): 61\u201365","journal-title":"Z Kardiol"},{"key":"BF1001354_CR23","first-page":"31","volume-title":"Cardiothoracic Interrelationships in Clinical Practice","author":"MA Matthay","year":"1997","unstructured":"Matthay MA, Tibayan FA . Mechanisms for the formation and reabsorption of pulmonary edema. In: Cosentino AM, Martin RJ (eds) Cardiothoracic Interrelationships in Clinical Practice Futura: Armonk, NY 1997 31\u201353"},{"key":"BF1001354_CR24","first-page":"69","volume-title":"Cardiothoracic Interrelationships in Clinical Practice","author":"PA Haddad","year":"1997","unstructured":"Haddad PA, Bailey CA, Gray A . Respiratory considerations in congestive heart failure: pathophysiology, assessment and management. In: Cosentino AM, Martin RJ (eds) Cardiothoracic Interrelationships in Clinical Practice Futura: Armonk, NY 1997 69\u2013122"},{"key":"BF1001354_CR25","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/oxfordjournals.eurheartj.a015386","volume":"18","author":"M Schaufelberger","year":"1997","unstructured":"Schaufelberger M et al. Skeletal muscle alterations inpatients with chronic heart failure Eur Heart J 1997 18: 971\u2013980","journal-title":"Eur Heart J"},{"key":"BF1001354_CR26","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1161\/01.CIR.86.3.909","volume":"86","author":"DM Mancini","year":"1992","unstructured":"Mancini DM, Henson D, LaManca J, Levine S . Respiratory muscle function and dyspnea inpatients with chronic congestive heart failure Circulation 1992 86: 909\u2013918","journal-title":"Circulation"},{"key":"BF1001354_CR27","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0140-6736(86)90298-9","volume":"2","author":"AJ Cowley","year":"1986","unstructured":"Cowley AJ et al. Symptomatic assessment ofpatients with heart failure: double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure Lancet 1986 2: 770\u2013772","journal-title":"Lancet"},{"key":"BF1001354_CR28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0002-9149(79)90049-3","volume":"43","author":"TL Biddle","year":"1979","unstructured":"Biddle TL, Yu PN . Effect of furosemide on hemodynamics and lung water in acute pulmonary edema secondary to myocardial infarction Am J Cardiol 1979 43: 86\u201390","journal-title":"Am J Cardiol"},{"key":"BF1001354_CR29","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/01.CIR.78.3.506","volume":"78","author":"MJ Sullivan","year":"1988","unstructured":"Sullivan MJ, Higginbotham MB, Cobb FR . Exercise training inpatients with severe left ventricular dysfunction: hemodynamic and metabolic effects Circulation 1988 78: 506\u2013515","journal-title":"Circulation"},{"key":"BF1001354_CR30","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1172\/JCI114771","volume":"86","author":"JR Minotti","year":"1990","unstructured":"Minotti JR et al. Skeletal muscle response to exercise training in congestive heart failure J Clin Invest 1990 86: 751\u2013758","journal-title":"J Clin Invest"},{"key":"BF1001354_CR31","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/0735-1097(93)90231-O","volume":"21","author":"S Adamapoulos","year":"1993","unstructured":"Adamapoulos S et al. Physical training improves skeletal muscle metabolism inpatients with chronic heart failure J Am Coll Cardiol 1993 21: 1101\u20131106","journal-title":"J Am Coll Cardiol"},{"key":"BF1001354_CR32","first-page":"1572","volume":"76","author":"JR Stratton","year":"1994","unstructured":"Stratton JR et al. Training partially reverses skeletal muscle metabolic abnormalities during exercise in heart failure J Clin Invest 1994 76: 1572\u20131582","journal-title":"J Clin Invest"},{"key":"BF1001354_CR33","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/0735-1097(94)00568-B","volume":"25","author":"R Hambrecht","year":"1995","unstructured":"Hambrecht R et al. Physical training inpatients with stable chronic heart failure: effects on cardiorepiratory fitness and ultrastructural abnormalities of leg muscles J Am Coll Cardiol 1995 25: 1239\u20131249","journal-title":"J Am Coll Cardiol"},{"key":"BF1001354_CR34","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1161\/01.CIR.85.6.2119","volume":"85","author":"AJS Coats","year":"1992","unstructured":"Coats AJS et al. Controlled trial of physical training in chronic heart failure: exercise performance, hemodynamics, ventilation, and autonomic function Circulation 1992 85: 2119\u20132131","journal-title":"Circulation"},{"key":"BF1001354_CR35","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/01.CIR.91.2.320","volume":"91","author":"DM Mancini","year":"1995","unstructured":"Mancini DM et al. Benefit of selective respiratory muscle training on exercise capacity inpatients with chronic congestive heart failure Circulation 1995 91: 320\u2013329","journal-title":"Circulation"},{"key":"BF1001354_CR36","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1378\/chest.110.4.985","volume":"110","author":"K Kiilavuory","year":"1999","unstructured":"Kiilavuory K et al. Effect of physical training on exercise capacity and gas exchange inpatients with chronic heart failure Chest 1999 110: 985\u2013991","journal-title":"Chest"},{"key":"BF1001354_CR37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1023\/A:1007835821228","volume":"13","author":"AJ Reyes","year":"1999","unstructured":"Reyes AJ, Taylor SH . Diuretics in cardiovascular medicine: the new clinicopharmacological bases that matter Cardiovasc Drugs Ther 1999 13: 371\u2013398","journal-title":"Cardiovasc Drugs Ther"},{"key":"BF1001354_CR38","first-page":"184","volume":"10","author":"H Vel\u00e1zquez","year":"1987","unstructured":"Vel\u00e1zquez H . Thiazide diuretics Renal Physiol 1987 10: 184\u2013197","journal-title":"Renal Physiol"},{"key":"BF1001354_CR39","first-page":"174","volume":"10","author":"R Greger","year":"1987","unstructured":"Greger R, Wangemann P . Loop diuretics Renal Physiol 1987 10: 174\u2013183","journal-title":"Renal Physiol"},{"key":"BF1001354_CR40","first-page":"198","volume":"10","author":"J-D Horisberger","year":"1987","unstructured":"Horisberger J-D, Giebisch G . Potassium-sparing diuretics Renal Physiol 1987 10: 198\u2013220","journal-title":"Renal Physiol"},{"key":"BF1001354_CR41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/eurheartj\/13.suppl_G.15","volume":"13 (Suppl G)","author":"AJ Reyes","year":"1992","unstructured":"Reyes AJ . Effects of diuretics on renal excretory function Eur Heart J 1992 13 (Suppl G): 15\u201321","journal-title":"Eur Heart J"},{"key":"BF1001354_CR42","first-page":"131","volume":"9","author":"AJ Reyes","year":"1992","unstructured":"Reyes AJ, Leary WP . Clinicopharmacological definition of the potency of diuretics and reclassification of diuretics by their clinicopharmacological potency Prog Pharmacol Clin Pharmacol 1992 9: 131\u2013146","journal-title":"Prog Pharmacol Clin Pharmacol"},{"key":"BF1001354_CR43","first-page":"391","volume-title":"Diuretics IV: Chemistry, Pharmacology and Clinical Applications","author":"WP Leary","year":"1993","unstructured":"Leary WP, Reyes AJ, van der Byl K . The antialdosterone substance spironolactone is a facultative natriuretic, antikaliuretic and antimagnesiuretic in man. In: Puschett JB, Greenberg A (eds) Diuretics IV: Chemistry, Pharmacology and Clinical Applications Excerpta Medica: Amsterdam 1993 391\u2013394"},{"key":"BF1001354_CR44","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B et al. The effect of spironolactone on morbidity and mortality inpatients with severe heart failure N Engl J Med 1999 341: 709\u2013717","journal-title":"N Engl J Med"},{"key":"BF1001354_CR45","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000175816","volume":"81","author":"KT Weber","year":"1992","unstructured":"Weber KT, Brilla CG, Campbell SE . Regulatory mechanisms of myocardial hypertrophy and fibrosis: results of in vivo studies Cardiology 1992 81: 266\u2013273","journal-title":"Cardiology"},{"key":"BF1001354_CR46","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s000590050024","volume":"25","author":"CG Brilla","year":"2000","unstructured":"Brilla CG . Aldosterone and myocardial fibrosis in heart failure Herz 2000 25: 299\u2013306","journal-title":"Herz"},{"key":"BF1001354_CR47","first-page":"33","volume":"10\/3","author":"BJ Materson","year":"1995","unstructured":"Materson BJ . Diuretic therapy of hypertension in the United States: low-dose becomes lower Prog Pharmacol Clin Pharmacol 1995 10\/3: 33\u201345","journal-title":"Prog Pharmacol Clin Pharmacol"},{"key":"BF1001354_CR48","first-page":"317","volume":"9","author":"WP Leary","year":"1992","unstructured":"Leary WP, Reyes AJ, van der Byl K . Interactions between different diuretics and between diuretics and other drugs on renal excretions in healthy man: mechanisms and clinical implications Prog Pharmacol Clin Pharmacol 1992 9: 317\u2013360","journal-title":"Prog Pharmacol Clin Pharmacol"},{"key":"BF1001354_CR49","first-page":"371","volume":"9","author":"K van der Byl","year":"1992","unstructured":"van der Byl K, Leary WP, Reyes AJ . Renal excretory actions of diuretics in congestive heart failure Prog Pharmacol Clin Pharmacol 1992 9: 371\u2013380 1992","journal-title":"Prog Pharmacol Clin Pharmacol"},{"key":"BF1001354_CR50","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1378\/chest.92.2.319","volume":"92","author":"AG Cutillo","year":"1987","unstructured":"Cutillo AG . The clinical assessment of lung water Chest 1987 92: 319\u2013325","journal-title":"Chest"},{"key":"BF1001354_CR51","first-page":"119","volume":"10\/3","author":"DC Brater","year":"1995","unstructured":"Brater DC . Diuretic resistance in chronic congestive heart failure: combinations of relatively low doses rather than very high doses Prog Pharmacol Clin Pharmacol 1995 10\/3: 119\u2013129","journal-title":"Prog Pharmacol Clin Pharmacol"},{"key":"BF1001354_CR52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/hrt.57.1.17","volume":"57","author":"J Bayliss","year":"1987","unstructured":"Bayliss J et al. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics Br Heart J 1987 57: 17\u201322","journal-title":"Br Heart J"},{"key":"BF1001354_CR53","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/S0735-1097(99)00435-0","volume":"34","author":"AS Westheim","year":"1999","unstructured":"Westheim AS et al. Hemodynamic and neuroendocrine effects for candoxatril and frusemide in mild stable chronic heart failure J Am Coll Cardiol 1999 34: 1794\u20131801","journal-title":"J Am Coll Cardiol"},{"key":"BF1001354_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-103-1-1","volume":"103","author":"GS Francis","year":"1985","unstructured":"Francis GS et al. Acute vasoconstrictor response to intravenous furosemide inpatients with chronic congestive heart failure Ann Intern Med 1985 103: 1\u20136","journal-title":"Ann Intern Med"},{"key":"BF1001354_CR55","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/978-1-4615-4871-3_53","volume":"449","author":"RW Schrier","year":"1998","unstructured":"Schrier RW, Martin PY . Recent advances in the understanding of water metabolism in heart failure Adv Exp Med Biol 1998 449: 415\u2013426","journal-title":"Adv Exp Med Biol"},{"key":"BF1001354_CR56","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1159\/000013496","volume":"19","author":"A Spital","year":"1999","unstructured":"Spital A . Diuretic-induced hyponatremia Am J Nephrol 1999 19: 447\u2013452","journal-title":"Am J Nephrol"},{"key":"BF1001354_CR57","first-page":"114A","volume":"13","author":"AJ Reyes","year":"2000","unstructured":"Reyes AJ, Leary WP . Kaliuretic potency of thirty-one oral formulations of diuretics: report on a study series in progress Am J Hypertens 2000 13: 114A (abstract)","journal-title":"Am J Hypertens"},{"key":"BF1001354_CR58","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1001\/archinte.160.16.2429","volume":"160","author":"JN Cohn","year":"2000","unstructured":"Cohn JN, Kowey PR, Whelton PK, Prisant LM . New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice Arch Intern Med 2000 160: 2429\u20132436","journal-title":"Arch Intern Med"},{"key":"BF1001354_CR59","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00005792-198511000-00001","volume":"64","author":"SP Ponce","year":"1985","unstructured":"Ponce SP, Jennings AE, Madias NE, Harrington JT . Drug-induced hyperkalemia Medicine 1985 64: 357\u2013370","journal-title":"Medicine"},{"key":"BF1001354_CR60","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00045391-199803000-00013","volume":"5","author":"RA Preston","year":"1998","unstructured":"Preston RA, Hirsh MJ, Oster JR, Oster HR . University of Miami Division of Clinical Pharmacology therapeutic rounds: drug-induced hyperkalemia Am J Ther 1998 5: 125\u2013132","journal-title":"Am J Ther"},{"key":"BF1001354_CR61","first-page":"551","volume":"19","author":"PA Friedman","year":"1999","unstructured":"Friedman PA, Bushinsky DA . Diuretic effects on calcium metabolism Semin Nephrol 1999 19: 551\u2013556","journal-title":"Semin Nephrol"},{"key":"BF1001354_CR62","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/ki.1978.58","volume":"13","author":"ER Yendt","year":"1978","unstructured":"Yendt ER, Cohanim M . Prevention of calcium stones with thiazides Kidney Int 1978 13: 397\u2013409","journal-title":"Kidney Int"},{"key":"BF1001354_CR63","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev.pa.26.040186.000533","volume":"26","author":"CT Stier","year":"1986","unstructured":"Stier CT, Itskovitz HD . Renal calcium metabolism and diuretics Annu Rev Pharmacol Toxicol 1986 26: 101\u2013116","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"BF1001354_CR64","first-page":"595","volume-title":"Diuretics IV: Chemistry, Pharmacology and Clinical Applications","author":"AJ Reyes","year":"1993","unstructured":"Reyes AJ, Leary WP, van der Byl K . Responses of urinary chloride, sodium, potassium and magnesium excretions to the addition of captopril to a combination of furosemide and amiloride. In: Puschett JB, Greenberg A (eds) Diuretics IV: Chemistry, Pharmacology and Clinical Applications Elsevier Science: Amsterdam 1993 595\u2013598"},{"key":"BF1001354_CR65","first-page":"169","volume-title":"Diuretics: Chemistry, Pharmacology, and Clinical Applications","author":"L Costanzo","year":"1984","unstructured":"Costanzo L . Effects of diuretics on the distal convoluted tubular transport of calcium. In: Puschett JB, Greenberg A (eds) Diuretics: Chemistry, Pharmacology, and Clinical Applications Elsevier: New York 1984 169\u2013173"},{"key":"BF1001354_CR66","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0272-6386(12)80667-6","volume":"24","author":"SM al-Ghamdi","year":"1994","unstructured":"al-Ghamdi SM, Cameron EC . Sutton RA. Magnesium deficiency: pathophysiologic and clinical overview Am J Kidney Dis 1994 24: 737\u2013752","journal-title":"Am J Kidney Dis"},{"key":"BF1001354_CR67","first-page":"87","volume":"6","author":"AJ Reyes","year":"1984","unstructured":"Reyes AJ, Leary WP . Diuretics and magnesium Magnes Bull 1984 6: 87\u201399","journal-title":"Magnes Bull"},{"key":"BF1001354_CR68","first-page":"113A\u2013114A","volume":"4","author":"AJ Reyes","year":"2000","unstructured":"Reyes AJ, Leary WP . Magnesiuretic potency of twenty-seven oral formulations of diuretics. Report on a study series in progress Am J Hypertens 2000 4: 113A\u2013114A (abstract)","journal-title":"Am J Hypertens"},{"key":"BF1001354_CR69","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/096032718400300501","volume":"3","author":"AJ Reyes","year":"1984","unstructured":"Reyes AJ, Leary WP . Cardiovascular toxicity of diuretics related to magnesium depletion Human Toxicol 1984 3: 351\u2013372","journal-title":"Human Toxicol"},{"key":"BF1001354_CR70","first-page":"93","volume":"9","author":"AJ Reyes","year":"1987","unstructured":"Reyes AJ . Interactions between magnesium and drugs in congestive heart failure Magnes Bull 1987 9: 93\u2013109","journal-title":"Magnes Bull"},{"key":"BF1001354_CR71","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1365-2796.2000.00585.x","volume":"247","author":"L Ceremuzynski","year":"2000","unstructured":"Ceremuzynski L, Gebalska J, Wolk R, Makowska E . Hypomagnesemia in heart failure with ventricular arrhythmias. Beneficial effects of magnesium supplementation J Intern Med 2000 247: 78\u201386","journal-title":"J Intern Med"},{"key":"BF1001354_CR72","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1432-2277.1999.tb01208.x","volume":"12","author":"SD Vannini","year":"1999","unstructured":"Vannini SD et al. Permanently reduced plasma ionized magnesium among renal transplant recipients on cyclosporine Transpl Int 1999 12: 244\u2013249","journal-title":"Transpl Int"},{"key":"BF1001354_CR73","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0002-8703(79)90108-X","volume":"97","author":"T Dyckner","year":"1979","unstructured":"Dyckner T, Wester PO . Ventricular extrasystoles and intracellular electrolytes before and after potassium and magnesium infusions inpatients on diuretic treatment Am Heart J 1979 97: 12\u201318","journal-title":"Am Heart J"},{"key":"BF1001354_CR74","first-page":"111","volume":"36","author":"JR Sowers","year":"1989","unstructured":"Sowers JR . The impact of diuretics on potassium and glucose J Cardiovasc Pharmacol 1989 36: 111\u2013117","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF1001354_CR75","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0163-7258(81)90102-9","volume":"12","author":"BL Furman","year":"1981","unstructured":"Furman BL . Impairment of glucose tolerance produced by diuretics and other drugs Pharmacol Ther 1981 12: 613\u2013649","journal-title":"Pharmacol Ther"},{"key":"BF1001354_CR76","doi-asserted-by":"crossref","first-page":"462","DOI":"10.2165\/00003495-198938030-00007","volume":"38","author":"SN Levine","year":"1989","unstructured":"Levine SN, Sanson TH . Treatment of hyperglycaemic hyperosmolar non-ketotic syndrome Drugs 1989 38: 462\u2013472","journal-title":"Drugs"},{"key":"BF1001354_CR77","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","volume":"283","author":"J Fang","year":"2000","unstructured":"Fang J, Alderman MH . Serum uric acid and cardiovascular mortality. The NHANES I epidemiologic follow-up study, 1971\u20131992 JAMA 2000 283: 2404\u20132410","journal-title":"JAMA"},{"key":"BF1001354_CR78","doi-asserted-by":"crossref","first-page":"197C","DOI":"10.1016\/S0735-1097(97)84590-1","volume":"31","author":"S Anker","year":"1998","unstructured":"Anker S et al. A simple predictor of impaired prognosis in chronic heart failure: uric acid J Am Coll Cardiol 1998 31: 197C (abstract)","journal-title":"J Am Coll Cardiol"},{"key":"BF1001354_CR79","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1054\/jcaf.2000.20558","volume":"6","author":"P Bettencourt","year":"2000","unstructured":"Bettencourt P et al. Predictors of prognosis inpatients with stable mild to moderate heart failure J Card Fail 2000 6: 306\u2013313","journal-title":"J Card Fail"},{"key":"BF1001354_CR80","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2165\/00003495-198121030-00003","volume":"21","author":"MW Johnson","year":"1981","unstructured":"Johnson MW, Mitch WE . The risks of asymptomatic hyperuricaemia and the use of uricosuric diuretics Drugs 1981 21: 220\u2013225","journal-title":"Drugs"},{"key":"BF1001354_CR81","doi-asserted-by":"crossref","first-page":"36A","DOI":"10.1016\/S0895-7061(00)00387-3","volume":"13","author":"M Mazzali","year":"2000","unstructured":"Mazzali M et al. An elevated serum uric acid (UA) causes kidney damage: evidence for a crystal independent mechanism Am J Hypertens 2000 13: 36A (abstract)","journal-title":"Am J Hypertens"},{"key":"BF1001354_CR82","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S1071-9164(99)91201-0","volume":"5 (Suppl 2)","author":"S Osaki","year":"1999","unstructured":"Osaki S et al. Impairment of urate excretion is an important mechanism for hyperuricemia inpatients with heart failure J Card Fail 1999 5 (Suppl 2): 60 (abstract)","journal-title":"J Card Fail"},{"key":"BF1001354_CR83","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1159\/000186593","volume":"59","author":"A Tykarski","year":"1991","unstructured":"Tykarski A . Evaluation of renal handling of uric acid in essential hypertension: hyperuricemia related to decreased urate secretion Nephron 1991 59: 364\u2013368","journal-title":"Nephron"},{"key":"BF1001354_CR84","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/00005344-199322003-00003","volume":"22 (Suppl 3)","author":"AJ Reyes","year":"1993","unstructured":"Reyes AJ . Renal excretory profiles of loop diuretics\u2014consequences for therapeutic application J Cardiovasc Pharmacol 1993 22 (Suppl 3): S11\u2013S23","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF1001354_CR85","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/bmj.300.6730.975","volume":"300","author":"JE Carlsen","year":"1990","unstructured":"Carlsen JE, Kober L, Torp-Pedersen C, Johansen C . Relations between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects Br Med J 1990 300: 975\u2013978","journal-title":"Br Med J"},{"key":"BF1001354_CR86","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM197912203012505","volume":"301","author":"ED Frohlich","year":"1979","unstructured":"Frohlich ED . Ticrynafen: a new thiazide-like but uricosuric antihypertensive diuretic N Engl J Med 1979 301: 1378\u20131382","journal-title":"N Engl J Med"},{"key":"BF1001354_CR87","first-page":"114A","volume":"13","author":"AJ Reyes","year":"2000","unstructured":"Reyes AJ, Leary WP, van der Byl K . Lack of effect of cicletanine on uric acid Am J Hypertens 2000 13: 114A (abstract)","journal-title":"Am J Hypertens"},{"key":"BF1001354_CR88","first-page":"91","volume":"82","author":"T Tarrade","year":"1989","unstructured":"Tarrade T et al. Efficacit\u00e9 antihypertensive et tol\u00e9rance du cicletanine. R\u00e9sultats obtenues en monoth\u00e9rapie sur une large population Arch Mal Coeur 1989 82: 91\u201397","journal-title":"Arch Mal Coeur"},{"key":"BF1001354_CR89","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF02125830","volume":"1","author":"WP Leary","year":"1987","unstructured":"Leary WP, Reyes AJ . Angiotensin I converting enzyme inhibitors and the renal excretion of urate Cardiovasc Drugs Ther 1987 1: 29\u201338","journal-title":"Cardiovasc Drugs Ther"},{"key":"BF1001354_CR90","doi-asserted-by":"crossref","first-page":"50F","DOI":"10.1016\/S0002-9149(99)80515-3","volume":"75","author":"AJ Reyes","year":"1995","unstructured":"Reyes AJ . Angiotensin-converting enzyme inhibitors in the clinical setting of congestive heart failure Am J Cardiol 1995 75: 50F\u201355F","journal-title":"Am J Cardiol"},{"key":"BF1001354_CR91","first-page":"37","volume":"2 (Suppl 2)","author":"AF Lant","year":"1984","unstructured":"Lant AF, McNabb RW, Noormohamed FH . Kinetic and metabolic aspects of enalapril action J Hypertens 1984 2 (Suppl 2): 37\u201342","journal-title":"J Hypertens"},{"key":"BF1001354_CR92","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1097\/00005344-198507001-00012","volume":"7 (Suppl 1)","author":"WP Leary","year":"1985","unstructured":"Leary WP, Reyes AJ, van der Byl K, Acosta-Barrios TN . Effects of captopril, hydrochlorothiazide and their combination on timed urinary excretion of water and electrolytes J Cardiovasc Pharmacol 1985 7 (Suppl 1): S56\u2013S62","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF1001354_CR93","first-page":"870","volume":"80","author":"M Labeeuw","year":"1987","unstructured":"Labeeuw M et al. Influence de l'administration aigu\u00eb du ramipril sur l'excr\u00e9tion d'acide urique Arch Mal Coeur 1987 80: 870\u2013874","journal-title":"Arch Mal Coeur"},{"key":"BF1001354_CR94","first-page":"235","volume-title":"Cardiovascular pharmacotherapy. Proceedings of the 9th International Congresson Cardiovascular Pharmacotherapy","author":"AJ Reyes","year":"2000","unstructured":"Reyes AJ . Uric acid in cardiovascular diseases and the uricosuric and hypouricaemic actions of angio-tensin-converting enzyme inhibitors In: Reyes AJ, Maranh\u00e3o MFC (eds) Cardiovascular pharmacotherapy. Proceedings of the 9th International Congresson Cardiovascular Pharmacotherapy Monduzzi: Bologna 2000 pp 235\u2013240"},{"key":"BF1001354_CR95","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF00266358","volume":"42","author":"M Nakashima","year":"1992","unstructured":"Nakashima M, Uematsu T, Kosuge K, Kanamuro M . Pilot study of the uricosuric effect of DuP-753, a new angiotensin II receptor antagonist, in healthy subjects Eur J Clin Pharmacol 1992 42: 333\u2013335","journal-title":"Eur J Clin Pharmacol"},{"key":"BF1001354_CR96","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1161\/01.HYP.26.1.112","volume":"26","author":"BA Soffer","year":"1995","unstructured":"Soffer BA et al. Effects of losartan on a background of hydrochlorothiazide inpatients with hypertension Hypertension 1995 26: 112\u2013117","journal-title":"Hypertension"},{"key":"BF1001354_CR97","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0895-7061(99)00053-9","volume":"12","author":"M Kochar","year":"1999","unstructured":"Kochar M et al. Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension Am J Hypertens 1999 12: 797\u2013805","journal-title":"Am J Hypertens"},{"key":"BF1001354_CR98","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00000441-200001000-00002","volume":"319","author":"A Greenberg","year":"2000","unstructured":"Greenberg A . Diuretic complications Am J Med Sci 2000 319: 10\u201324","journal-title":"Am J Med Sci"},{"key":"BF1001354_CR99","first-page":"3","volume":"8\/1","author":"JB Puschett","year":"1990","unstructured":"Puschett JB, Lupinacci Jordan L . Mode of action of torasemide in man Prog Pharmacol Clin Pharmacol 1990 8\/1: 3\u201313","journal-title":"Prog Pharmacol Clin Pharmacol"},{"key":"BF1001354_CR100","first-page":"440","volume":"21","author":"AJ Reyes","year":"2000","unstructured":"Reyes AJ, Leary WP, Espinas RD, van der Byl K . The loop diuretic torasemide does not act on the proximal tubule of the nephron Eur Heart J 2000 21: 440 (abstract)","journal-title":"Eur Heart J"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1001354.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1001354","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1001354.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T20:33:57Z","timestamp":1647549237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1001354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3,1]]},"references-count":100,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2002,3,1]]}},"alternative-id":["BF1001354"],"URL":"https:\/\/doi.org\/10.1038\/sj.jhh.1001354","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3,1]]},"assertion":[{"value":"24 April 2002","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}